These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12946830)

  • 1. Targeted therapies for the treatment of cancer.
    Kim JA
    Am J Surg; 2003 Sep; 186(3):264-8. PubMed ID: 12946830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibiting tyrosine kinases: successes and limitations.
    Arteaga CL
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S79-83. PubMed ID: 14508084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of molecular targeted agents in oncology.
    Soria JC; Blay JY; Spano JP; Pivot X; Coscas Y; Khayat D
    Ann Oncol; 2011 Aug; 22(8):1703-16. PubMed ID: 21300696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Herceptin and Gleevec.
    Fischer OM; Streit S; Hart S; Ullrich A
    Curr Opin Chem Biol; 2003 Aug; 7(4):490-5. PubMed ID: 12941424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular targeted therapy].
    Stenner-Liewen F; Zippelius A; Pestalozzi BC; Knuth A
    Chirurg; 2006 Dec; 77(12):1118-25. PubMed ID: 17109101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances of molecular targeted agents: opportunities for imaging.
    Dancey JE
    Cancer Biol Ther; 2003; 2(6):601-9. PubMed ID: 14688462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineoplastic agents targeting tyrosine kinases].
    Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic molecular marker and molecular targeted-therapy in pediatric malignancies].
    Hayashi Y
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):194-202. PubMed ID: 17301526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
    Stathopoulos GP
    Oncol Rep; 2002; 9(6):1257-9. PubMed ID: 12375030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies for cancer 2004.
    Ross JS; Schenkein DP; Pietrusko R; Rolfe M; Linette GP; Stec J; Stagliano NE; Ginsburg GS; Symmans WF; Pusztai L; Hortobagyi GN
    Am J Clin Pathol; 2004 Oct; 122(4):598-609. PubMed ID: 15487459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular therapy of breast carcinoma in the advanced phase].
    Foggi P; Amodio A
    Tumori; 2003; 89(4 Suppl):189-91. PubMed ID: 12903589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tyrosine kinases. New target of anticancer therapy].
    Majsterek I; Pytel D; Błasiak J
    Postepy Biochem; 2005; 51(3):251-60. PubMed ID: 16381169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resistance to target-based therapy and its circumvention].
    Nishio K
    Nihon Rinsho; 2004 Jul; 62(7):1343-7. PubMed ID: 15283154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanisms of the resistance to molecular targeting agents].
    Akiyama S
    Nihon Rinsho; 2004 Jul; 62(7):1297-304. PubMed ID: 15283147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitors: a clinical perspective.
    Goel S; Mani S; Perez-Soler R
    Curr Oncol Rep; 2002 Jan; 4(1):9-19. PubMed ID: 11734109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted chronic myeloid leukemia therapy: Seeking a cure.
    Fausel C
    Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.